Please use this identifier to cite or link to this item:
Title: Haplotype analysis of the internationally distributed BRCA1 c.3331_3334delCAAG founder mutation reveals a common ancestral origin in Iberia
Author: Asis Tuazon, Anna Marie De
Lott, Paul
Bohorquez, Mabel
Benavides, Jennyfer
Ramirez, Carolina
Criollo, Angel
Estrada Florez, Ana
Mateus, Gilbert
Velez, Alejandro
Carmona, Jenny
Olaya, Justo
Garcia, Elisha
Polanco Echeverry, Guadalupe
Stultz, Jacob
Alvarez, Carolina
Tapia, Teresa
Ashton Prolla, Patricia
Vega, Ana
Lázaro García, Conxi
Tornero, Eva
Martinez Bouzas, Cristina
Infante, Mar
Hoya, Miguel De La
Diez, Orland
Browning, Brian L.
Rannala, Bruce
Teixeira, Manuel R.
Carvallo, Pilar
Echeverry, Magdalena
Carvajal Carmona, Luis G.
Brazilian Familial Cancer Network
COLUMBUS Consortium
Keywords: Càncer de mama
Càncer d'ovari
Breast cancer
Ovarian cancer
Issue Date: 21-Oct-2020
Publisher: BioMed Central
Abstract: Background: TheBRCA1c.3331_3334delCAAG founder mutation has been reported in hereditary breast and ovarian cancer families from multiple Hispanic groups. We aimed to evaluateBRCA1c.3331_3334delCAAG haplotype diversity in cases of European, African, and Latin American ancestry. Methods: BC mutation carrier cases from Colombia (n = 32), Spain (n = 13), Portugal (n = 2), Chile (n = 10), Africa (n = 1), and Brazil (n = 2) were genotyped with the genome-wide single nucleotide polymorphism (SNP) arrays to evaluate haplotype diversity aroundBRCA1c.3331_3334delCAAG. Additional Portuguese (n = 13) and Brazilian (n = 18) BC mutation carriers were genotyped for 15 informative SNPs surroundingBRCA1. Data were phased using SHAPEIT2, and identical by descent regions were determined using BEAGLE and GERMLINE. DMLE+ was used to date the mutation in Colombia and Iberia. Results: The haplotype reconstruction revealed a shared 264.4-kb region among carriers from all six countries. The estimated mutation age was similar to 100 generations in Iberia and that it was introduced to South America early during the European colonization period. Conclusions: Our results suggest that this mutation originated in Iberia and later introduced to Colombia and South America at the time of Spanish colonization during the early 1500s. We also found that the Colombian mutation carriers had higher European ancestry, at the BRCA1 gene harboring chromosome 17, than controls, which further supported the European origin of the mutation. Understanding founder mutations in diverse populations has implications in implementing cost-effective, ancestry-informed screening.
Note: Reproducció del document publicat a:
It is part of: Breast Cancer Research, 2020, vol. 22
Related resource:
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
TuazonAMD.pdf3.8 MBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons